UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): December 22, 2005
CONMED CORPORATION
(Exact name of registrant as specified in its charter)
New York |
|
0-16093 |
|
16-0977505 |
|
(State or other jurisdiction of |
|
(Commission |
|
(I.R.S. Employer |
|
incorporation or organization) |
|
File Number) |
|
Identification No.) |
|
525 French Road
Utica, New York 13502
(Address of principal executive offices, including zip code)
(315) 797-8375
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act | ||
|
(17 CFR 240.14d-2(b)) |
| |
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act | ||
|
(17 CFR 240.13e-4(c)) |
| |
Section 2 |
Financial Information |
Item 2.02 |
Results of Operations and Financial Condition. |
On December 22, 2005, CONMED Corporation issued a press release setting forth revised earnings guidance for the quarter ended December 31, 2005. A copy of this press release is attached hereto as Exhibit 99.1.
The information in this Current Report on Form 8-K that is furnished under Item 2.02. Results of Operations and Financial Condition and Exhibit 99.1 attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Section 9 |
Financial Statements and Exhibits |
Item 9.01 |
Financial Statements and Exhibits. |
|
(c) Exhibits |
|
|
|
The following exhibit is included herewith: |
|
Exhibit No. |
Description of Exhibit |
|
|
|
|
99.1 |
Press Release dated December 22, 2005, issued by CONMED Corporation. |
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
CONMED CORPORATION |
|
(Registrant) |
|
|
|
|
|
By: /s/ Robert D. Shallish, Jr. |
|
Vice President-Finance and |
|
Chief Financial Officer |
|
|
Date: |
December 22, 2005 |
EXHIBIT INDEX
Exhibit |
|
Number |
Exhibit Description |
|
|
Press Release, dated December 22, 2005, issued by CONMED Corporation. | |
|
|